21st Century Cures Act 2.0 Discussion Draft

As part of its advocacy program in the United States, ACRO submits regulatory comments to US regulators. This comment letter, submitted by ACRO to the U.S. Congress in July 2021 about the 21st Century Cures Act 2.0 Discussion Draft.